Your browser doesn't support javascript.
loading
Pharmacovigilance in developing countries (part I): importance and challenges.
Elshafie, Shaimaa; Zaghloul, Iman; Roberti, Anne Marie.
Affiliation
  • Elshafie S; National Organization for Drug Control and Research, Cairo, Egypt. shaimaaelshafie83@gmail.com.
  • Zaghloul I; Massachusetts College of Pharmacy and Health Sciences University, Boston, MA, USA. shaimaaelshafie83@gmail.com.
  • Roberti AM; Massachusetts College of Pharmacy and Health Sciences University, Boston, MA, USA.
Int J Clin Pharm ; 40(4): 758-763, 2018 Aug.
Article in En | MEDLINE | ID: mdl-29248988
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ethnicity / Adverse Drug Reaction Reporting Systems / Developing Countries / Drug-Related Side Effects and Adverse Reactions / Pharmacovigilance Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Aspects: Determinantes_sociais_saude / Equity_inequality / Patient_preference Limits: Humans Language: En Journal: Int J Clin Pharm Year: 2018 Document type: Article Affiliation country: Egipto Country of publication: Países Bajos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ethnicity / Adverse Drug Reaction Reporting Systems / Developing Countries / Drug-Related Side Effects and Adverse Reactions / Pharmacovigilance Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Aspects: Determinantes_sociais_saude / Equity_inequality / Patient_preference Limits: Humans Language: En Journal: Int J Clin Pharm Year: 2018 Document type: Article Affiliation country: Egipto Country of publication: Países Bajos